DEUTSCHE BANK AG\ - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 68 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q2 2019$66,000
-73.6%
140,817
-24.8%
0.00%
Q1 2019$250,000
-78.7%
187,222
-82.0%
0.00%
-100.0%
Q4 2018$1,174,000
+84.0%
1,040,447
+348.8%
0.00%
Q3 2018$638,000
-29.0%
231,808
-8.0%
0.00%
Q2 2018$899,000
-36.0%
252,097
-44.9%
0.00%
-100.0%
Q1 2018$1,405,000
+0.8%
457,894
+106.8%
0.00%0.0%
Q4 2017$1,394,000
+148.0%
221,425
+168.6%
0.00%
Q3 2017$562,000
-37.6%
82,429
-34.8%
0.00%
-100.0%
Q2 2017$900,000
-45.5%
126,422
-29.8%
0.00%0.0%
Q1 2017$1,652,000
+58.8%
179,964
-30.4%
0.00%0.0%
Q4 2016$1,040,000
-22.0%
258,670
-25.8%
0.00%0.0%
Q3 2016$1,333,000
-1.8%
348,433
+10.2%
0.00%0.0%
Q2 2016$1,358,000
-10.5%
316,061
-3.8%
0.00%0.0%
Q1 2016$1,518,000
+28.0%
328,468
+176.9%
0.00%0.0%
Q4 2015$1,186,000
+167.1%
118,606
+98.3%
0.00%
Q3 2015$444,000
-78.1%
59,801
+40.0%
0.00%
-100.0%
Q2 2015$2,025,000
-2.6%
42,722
-24.7%
0.00%0.0%
Q1 2015$2,079,000
+531.9%
56,765
+584.1%
0.00%
Q4 2014$329,000
-77.7%
8,298
-88.8%
0.00%
-100.0%
Q3 2014$1,478,000
+28.4%
74,173
-13.1%
0.00%0.0%
Q2 2014$1,151,000
+1727.0%
85,390
+1357.7%
0.00%
Q1 2014$63,000
+70.3%
5,858
+109.4%
0.00%
Q4 2013$37,000
-76.1%
2,797
-79.6%
0.00%
Q3 2013$155,00013,7270.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q2 2019
NameSharesValueWeighting ↓
Opaleye Management Inc. 330,000$2,353,0000.98%
EcoR1 Capital, LLC 633,400$4,516,0000.80%
DLD Asset Management, LP 570,000$4,059,0000.53%
Rhenman & Partners Asset Management AB 300,000$2,139,0000.31%
Eventide Asset Management 600,000$4,278,0000.27%
Tekla Capital Management LLC 1,004,322$7,161,0000.26%
Rock Springs Capital Management LP 698,000$4,977,0000.25%
DLD Asset Management, LP 230,000$1,640,0000.21%
Worth Venture Partners, LLC 29,325$209,0000.18%
Crestline Management, LP 161,403$1,151,0000.15%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders